Bionano Genomics Inc.

1.66+0.0700+4.40%Vol 1.27M1Y Perf -91.97%
Dec 1st, 2023 16:00 DELAYED
BID1.63 ASK1.68
Open1.63 Previous Close1.59
Pre-Market- After-Market1.64
 - -  -0.02 -1.20%
Target Price
7.38 
Analyst Rating
Strong Buy 1.40
Potential %
344.58 
Finscreener Ranking
★★★★+     57.51
Insiders Trans % 3/6/12 mo.
100/100/100 
Value Ranking
★★★+     54.59
Insiders Value % 3/6/12 mo.
100/100/100 
Growth Ranking
★★★★+     61.53
Insiders Shares Cnt. % 3/6/12 mo.
100/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
2.16 
Earnings Rating
Neutral
Market Cap64.47M 
Earnings Date
8th Nov 2023
Alpha0.03 Standard Deviation0.80
Beta2.29 

Today's Price Range

1.511.67

52W Range

1.1922.90

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
-3.64%
1 Month
19.55%
3 Months
-58.70%
6 Months
-78.28%
1 Year
-91.97%
3 Years
-68.45%
5 Years
-97.73%
10 Years
-

TickerPriceChg.Chg.%
BNGO1.660.07004.40
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
Financial StrengthValueIndustryS&P 500US Markets
5.60
6.50
0.03
0.04
-441.40
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
16.90
-472.30
-437.90
-324.30
-
RevenueValueIndustryS&P 500US Markets
19.59M
0.07
15.70
13.09
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.90-1.24-37.78
Q01 2023-0.90-1.20-33.33
Q04 2022-0.90-1.30-44.44
Q03 2022-1.20-1.108.33
Q02 2022-1.00-1.10-10.00
Q01 2022-0.80-1.10-37.50
Q04 2021-0.07-0.08-14.29
Q03 2021-0.06-0.07-16.67
Earnings Per EndEstimateRevision %Trend
12/2023 QR-0.77-2.67Negative
12/2023 QR-0.773.75Positive
12/2023 FY-2.18-190.67Negative
12/2024 FY-2.8518.57Positive
Next Report Date-
Estimated EPS Next Report-0.75
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume1.27M
Shares Outstanding38.84K
Shares Float37.89M
Trades Count6.47K
Dollar Volume2.02M
Avg. Volume1.22M
Avg. Weekly Volume1.49M
Avg. Monthly Volume1.25M
Avg. Quarterly Volume912.94K

Bionano Genomics Inc. (NASDAQ: BNGO) stock closed at 1.59 per share at the end of the most recent trading day (a 0.63% change compared to the prior day closing price) with a volume of 2.46M shares and market capitalization of 64.47M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Equipment & Supplies industry, Healthcare sector and employs 405 people. Bionano Genomics Inc. CEO is R. Erik Holmlin.

The one-year performance of Bionano Genomics Inc. stock is -91.97%, while year-to-date (YTD) performance is -89.11%. BNGO stock has a five-year performance of -97.73%. Its 52-week range is between 1.19 and 22.9, which gives BNGO stock a 52-week price range ratio of 2.16%

Bionano Genomics Inc. currently has a PE ratio of -3.60, a price-to-book (PB) ratio of 1.54, a price-to-sale (PS) ratio of 23.50, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -34.20%, a ROC of -36.45% and a ROE of -37.50%. The company’s profit margin is -%, its EBITDA margin is -437.90%, and its revenue ttm is $19.59 Million , which makes it $0.07 revenue per share.

Of the last four earnings reports from Bionano Genomics Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.75 for the next earnings report. Bionano Genomics Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Bionano Genomics Inc. is Strong Buy (1.4), with a target price of $7.38, which is +344.58% compared to the current price. The earnings rating for Bionano Genomics Inc. stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Bionano Genomics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Bionano Genomics Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 26.02, ATR14 : 0.16, CCI20 : 133.66, Chaikin Money Flow : -0.17, MACD : -0.09, Money Flow Index : 61.54, ROC : 22.31, RSI : 48.77, STOCH (14,3) : 67.80, STOCH RSI : 0.81, UO : 44.97, Williams %R : -32.20), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Bionano Genomics Inc. in the last 12-months were: Mamuszka Hannah (Buy at a value of $50 000), R. Erik Holmlin (Buy at a value of $9 600)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (80.00 %)
6 (100.00 %)
6 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
1 (20.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.40
Strong Buy
1.00
Strong Buy
1.00

Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.

CEO: R. Erik Holmlin

Telephone: +1 858 888-7600

Address: 9540 Towne Centre Drive,Suite 100, San Diego 92121, CA, US

Number of employees: 405

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

54%46%

Bearish Bullish

56%44%

 

News

Stocktwits